Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase 3 trial of VAD vs VCE in stage IV childhood renal tumour
DRKS00021160Phase 3Recruiting
- Sponsor
- German Society for Pediatric Oncology and Hematology
- Start
- May 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of vincristine, actinomycin D, doxorubicin, carboplatin, etoposide in Nephroma, kidney cancer, sponsored by German Society for Pediatric Oncology and Hematology. Started May 2020; status: recruiting.
02
Drugs
vincristineactinomycin Ddoxorubicincarboplatinetoposide
03
Conditions
Nephromakidney cancer
Beyond the preview
Go deeper on DRKS00021160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00021160.